Methods of using optical agents

Patent metadata

Field	Value
Publication number	US-9283288-B2
Application number	US-99527006-A
Country	US
Kind code	B2
Filing date	Oct 11, 2006
Priority date	Feb 24, 2006
Publication date	Mar 15, 2016
Grant date	Mar 15, 2016

Abstract

In certain aspects, the invention relates to processes for using renally excretable optical agents to detect one or more tissues of the renal system of a surgical patient. In certain aspects, the invention relates to a kit including a biocompatible composition containing one or more optical agents and instructions for using the optical agent(s) in a process of the present invention.

First claim

What is claimed is:

1. A process for using a fluorescent agent in an abdominal or pelvic surgical procedure to reduce the risk of accidental injury to a ureter of a patient undergoing an abdominal or pelvic surgical procedure, the process comprising:
delivering a fluorescent agent to the ureter of a patient undergoing an abdominal or pelvic surgical procedure,
wherein the fluorescent agent is delivered intravenously, enterally, intraperitoneally, transdermally, or via inhalation to the patient,
wherein at least a fraction of the fluorescent agent is excreted through the renal system such that at least a fraction of the fluorescent agent is present in the patient's urine,
wherein the fluorescent agent is chosen from phenylxanthenes, phenothiazines, phenoselenazines, cyanines, indocyanines, squaraines, dipyrrolo pyrimidones, anthraquinones, tetracenes, quinolines, pyrazines, acridines, acridones, phenanthridines, azo dyes, rhodamines, phenoxazines, azulenes, azaazulenes, triphenyl methane dyes, indoles, benzoindoles, indocarbocyanines, benzoindocarbocyanines, derivatives having the general structure of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene, and conjugates thereof and derivatives thereof,
irradiating a ureter of the patient's renal system with non-ionizing radiation to cause the fluorescent agent to fluoresce within the ureter; and
optically detecting the fluorescent agent in the irradiated ureter to distinguish the ureter from surrounding tissues and reduce the risk of accidental injury to the ureter.

2. The process of claim 1 , wherein the fluorescent agent is selected from phenylxanthenes, phenothiazines, phenoselenazines, cyanines, indocyanines, squaraines, dipyrrolo pyrimidones, anthraquinones, tetracenes, quinolines, pyrazines, acridines, acridones, phenanthridines, azo dyes, rhodamines, phenoxazines, azulenes, azaazulenes, triphenyl methane dyes, indoles, benzoindoles, indocarbocyanines, benzoindocarbocyanines, conjugates thereof and derivatives thereof.

3. The process of claim 1 , wherein the fluorescent agent is selected from fluorescein, and 3,6-diaminopyrazine-2,5-dicarboxylic acid.

4. The process of claim 1 , wherein the non-ionizing radiation is selected from visible radiation, ultraviolet radiation, infrared radiation, and combinations thereof.

5. The process of claim 1 , wherein the fluorescent agent is detected using at least one of unaided eye, camera, charged coupled device, photomultiplier tube, avalanche diode, and photodiodes.

6. The process of claim 1 , wherein the abdominal or pelvic surgical procedure is selected from total or partial hysterectomy, oophorectomy, tubal ligation, surgical removal of ovarian cysts, anterior repair of the vaginal wall, caesarean section, repair of a pelvic prolapse, pelvic mass resection, removal of a fallopian tube, adnexectomy, removal of an ectopic pregnancy, vasectomy, prostatectomy, hernia repair surgery, colectomy, cholecystectomy, appendectomy, hepatobiliary surgery, splenectomy, distal or total pancreatectomy, the Whipple procedure, and abdominal or pelvic lymphadenectomy.

7. A kit comprising a biocompatible composition containing a fluorescent agent, and instructions for using the composition in the process of claim 1 .

8. The process of claim 1 , wherein the abdominal or pelvic surgical procedure is not renal transplantation surgery.

Assignees

• Dorshow Richard B
• Rajagopalan Raghavan
• Moore Dennis A
• Depierro Scott T
• Medibeacon Inc

Inventors

• Dorshow Richard B
• Rajagopalan Raghavan
• Moore Dennis A
• Depierro Scott T

Classifications

• A61B5/418

  lymph vessels, ducts or nodes · CPC title

• A61B5/0036

  including treatment, e.g., using an implantable medical device, ablating, ventilating · CPC title

• A61K49/0021 Primary

  the fluorescent group being a small organic molecule · CPC title

• A61B2017/00274

  Prostate operation, e.g. prostatectomy, turp, bhp treatment · CPC title

• A61B5/20

  for measuring urological functions {restricted to the evaluation of the urinary system (A61B5/4375 takes precedence)} · CPC title